Sichuan Nigale Biomedical Co., Ltd.
Trade Assurance
The supplier supports Trade Assurance – A free service that protects your orders from payment to delivery.
Suppliers Trade Assurance Limit:US $10,000
Gold Supplier
Gold Supplier is a premium membership for suppliers on Alibaba.com. Members are provided with comprehensive ways to promote their products, maximizing product exposure and increasing return-on-investment.
Sichuan Nigale Biomedical Co., Ltd.
Sichuan, China
Why Choose Us
Focusing on manufacturing whole series of blood processing and apheresis systems, including disposables and devices. Nigale is an enterprise specialized in manufacturing automated blood processing devices and disposable kits. Its headquarter is located in Chengdu, the capital of Sichuan province which has been historically known as the Province of Abundance, its production base is in Jianyang and Beijing Nigale as its fully-capital subsidiary company is in Beijing.
Founded in 1994, Nigale focuses on products in the field of transfusion medicine and gets strong technical support from the Institute of Blood Transfusion and Hematology of the Chinese Academy of Medical Sciences as well as the Sichuan Provincial Academy of Medical Sciences. Nigale was altered into a limited liability company in August 2001 and finally transformed into a private limited liability company in March 2004.
Today Nigale has grown into a national leader in the manufacturing, selling and services of blood processing systems in China. We have won over twenty patents for invention,patent of utility model and software. Our entire products have Chinese SFDA certificates, ISO13485 certificate,CMDCAS certificate and CE marks. They meet all the needs and requirements of international standards in quality, variety specification and services.
Nigale products are mainly used in blood cells separating & filtering,plasma exchanging therapy as well as operation room and clinical therapies in hospitals.

NIGALE's Plasma Separator Products Are Widely Used in Convalescent Plasma Treatment for COVID-19

 

China has developed convalescent plasma to treat patients who are infected with the COVID-19. After strict blood biosafety tests, virus inactivation and antiviral activity tests, they have successfully used it to treat critically ill patients. What hyperimmune globulin does is it concentrates the antibodies in a recovered patient. You are essentially giving the new victim's immune system a boost of antibodies to hopefully get them through the very difficult phase. 

Three critically ill patients in a hospital in the Jiangxia District of Wuhan received convalescent plasma treatment on Feb. 8. Currently, more than 10 critically ill patients have received the treatment. According to clinical results, 12 to 24 hours after the patients received the treatment, they have shown improved clinical symptoms, with main inflammatory indexes decreased significantly and some key indexes such as blood oxygen saturation improving comprehensively. 

Dr. Kong Yuefeng, a recovered COVID-19 patient, donates plasma via Blood component separator XCF3000 from Sichuan Nigale Biotechnology Co., Ltd. in Wuhan blood center in central China's Hubei province on Tuesday (Feb 18).

Send message to supplier

Messeage has been sent sucessfully.

Check your messeages on Messeage Center, the supplier willcontacts you soon.